Study identifies potential new drug for Parkinson’s-related cognitive decline, dementia

A recently published study by researchers at the University of Arizona Health Sciences found that a tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson’s disease and related disorders.

Click here to view the original article.